Keywords: نیمه عمر حذف ترمینال; anti-infectives; bioavailability; clinical pharmacokinetics; formulation; oral absorption; pharmacokinetics; HCV; hepatitis C virus; GT; genotype; DAA; direct-acting antiviral; RBV; ribavirin; GLE; glecaprevir; PIB; pibrentasvir; Cmax; maximum plasma conc
مقالات ISI نیمه عمر حذف ترمینال (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: نیمه عمر حذف ترمینال; AUC; area under the curve; BZD; benzodiazepine; Cl; total clearance; Cmax; peak concentration; CNS; central nervous system; DOPAC; 3,4-dihydroxyphenylacetic acid; DZP; diazepam; GABA; γ-aminobutyric acid; EEG; electroencephalogram;; f; respiratory freque
Effects of sulfur-fumigation on the pharmacokinetics, metabolites and analgesic activity of Radix Paeoniae Alba
Keywords: نیمه عمر حذف ترمینال; AUC; area under the plasma concentration-time curve; BS; Radix Paeoniae Alba; CID; collision-induced dissociation; CL; clearance; Cmax; maximum plasma concentration; FDA; US Food and Drug Administration; HPLC/UV; high performance liquid chromatography/u
Repeated administration of Sailuotong, a fixed combination of Panax ginseng, Ginkgo biloba, and Crocus sativus extracts for vascular dementia, alters CYP450 activities in rats
Keywords: نیمه عمر حذف ترمینال; Sailuotong; Panax ginseng; Ginkgo biloba; Crocus sativus; CYP450; Herb-drug interaction; Abbreviation: SLT; Sailuotong; VD; vascular dementia; TCM; traditional Chinese medicines; DDI; drug-drug interaction; CYP450; cytochrome P450; SPE; solid phase extrac
A rapid and sensitive UHPLC-MS/MS method for quantification of 83b1 in plasma and its application to bioavailability study in rats
Keywords: نیمه عمر حذف ترمینال; UHPLC-MS/MS; ultra-high performance liquid chromatography tandem mass spectrometry; ESCC; esophageal squamous cell carcinoma; PPAR; peroxisome proliferator-activated receptor; CDDP; cisplatin; COX-2; cyclooxygenase-2; PGH; prostaglandin H; MTS; 3-(4,5-d
A phase 1 study to evaluate the safety and pharmacokinetics of MEDI8852, an anti-influenza A monoclonal antibody, in healthy adult volunteers
Keywords: نیمه عمر حذف ترمینال; MEDI8852; Monoclonal antibody; Influenza; Hemagglutinin; ADA; anti-drug antibodies; AUC0-t; area under the concentrationâtime curve from time 0 to last sampling time point; AUCâ; area under the plasma concentrationâtime curve from time 0 to infinity
Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month period
Keywords: نیمه عمر حذف ترمینال; AMP; (+)-amphetamine; i.v.; intravenous; AMP-d11; 1,1,2,3,3,3-hexadeutero-1-pentadeuterophenyl-2-aminopropane; KD; equilibrium dissociation rate constant; LC-MS/MS; liquid chromatography coupled to tandem mass spectrometry; mAb; monoclonal antibody; MET
Antenatal Pharmacokinetics and Placental Transfer of N-Acetylcysteine in Chorioamnionitis for Fetal Neuroprotection
Keywords: نیمه عمر حذف ترمینال; C:M; Cord/maternal; CA; Chorioamnionitis; CL; Clearance; GA; Gestational age; GSH; Glutathione; IV; Intravenous; NAC; N-acetylcysteine; PK; Pharmacokinetic; t1/2; Terminal elimination half-life; Vd; Volume of distribution;
Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations
Keywords: نیمه عمر حذف ترمینال; AmB; Amphotericin B; RBCs; red blood cells; RES; reticulo-endothelial system; FD; non-microencapsulated free dimeric AmB formulation; F; Fungizone®; HF; heated-Fungizone; MD; microencapsulated dimer AmB; FP; non-microencapsulated free poly-aggregated AmB